BMS 1612 (Baraclude 1 mg)
Generic Name: entecavir
Pill with imprint BMS 1612 is Pink, Three-sided and has been identified as Baraclude 1 mg. It is supplied by Bristol-Myers Squibb.
Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 1612
Baraclude
- Generic Name:
- entecavir
- Imprint:
- BMS 1612
- Strength:
- 1 mg
- Color:
- Pink
- Shape:
- Three-sided
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
ferric oxide red
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 49884-0105 | Par Pharmaceutical, Inc. |
More about Baraclude (entecavir)
- Baraclude Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Baraclude
- Baraclude (Entecavir Oral Solution)
- Baraclude (Entecavir Tablets)
- Baraclude (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
